• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎遗传学的最新进展。

Update on primary sclerosing cholangitis genetics.

机构信息

aDivision of Cancer Medicine, Surgery and Transplantation, Department of Transplantation Medicine, Norwegian PSC Research Center, Oslo University Hospital Rikshospitalet bDivision of Cancer Medicine, Surgery and Transplantation, K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo cDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.

出版信息

Curr Opin Gastroenterol. 2014 May;30(3):310-9. doi: 10.1097/MOG.0000000000000052.

DOI:10.1097/MOG.0000000000000052
PMID:24565892
Abstract

PURPOSE OF REVIEW

The pathogenesis of primary sclerosing cholangitis (PSC) involves heritable factors. This review summarizes the recent genetic studies and discusses the implications of identified risk loci.

RECENT FINDINGS

A total of 16 PSC susceptibility loci have been identified in genome-wide association studies and related study designs. At least 33 additional loci are involved in what is increasingly acknowledged to represent a general pool of genetic risk loci for immune-mediated diseases. One important group of genes is part of well characterized immune pathways (e.g. interleukin 2 signaling), whereas for other loci the relationship to PSC pathophysiology is less evident. Importantly, the loci collectively account for only 7.3% of overall PSC liability, thus pointing to a large contribution from environmental factors to PSC development. The individual PSC risk genes cannot be interpreted within a simple cause-effect model used for monogenic traits, but need to be explored for their individual biological correlates, preferably in a disease context. To some extent, as exemplified for the human leukocyte antigen and FUT2 associations, genetic findings may guide the discovery of interacting and co-occuring environmental susceptibility factors.

SUMMARY

Multiple PSC susceptibility loci are now available for exploration in experimental model systems and patient-centered research.

摘要

目的综述

原发性硬化性胆管炎(PSC)的发病机制涉及遗传因素。本综述总结了最近的遗传研究,并讨论了已确定的风险基因座的意义。

最近的发现

全基因组关联研究和相关研究设计已确定了 16 个 PSC 易感性基因座。至少还有 33 个额外的基因座涉及越来越被认为是免疫介导性疾病遗传风险基因座的一般池。一组重要的基因是特征明确的免疫途径的一部分(例如白细胞介素 2 信号转导),而对于其他基因座,与 PSC 病理生理学的关系则不那么明显。重要的是,这些基因座总共仅占 PSC 总易感性的 7.3%,这表明环境因素对 PSC 发病机制有很大贡献。个体 PSC 风险基因不能用单基因性状的简单因果模型来解释,而需要在疾病背景下探索其个体生物学相关性。在某种程度上,正如人类白细胞抗原和 FUT2 相关性的例子所示,遗传发现可能有助于发现相互作用和共同发生的环境易感性因素。

总结

现在有多个 PSC 易感性基因座可供实验模型系统和以患者为中心的研究探索。

相似文献

1
Update on primary sclerosing cholangitis genetics.原发性硬化性胆管炎遗传学的最新进展。
Curr Opin Gastroenterol. 2014 May;30(3):310-9. doi: 10.1097/MOG.0000000000000052.
2
A lecture on the genetics of primary sclerosing cholangitis.原发性硬化性胆管炎的遗传学讲座。
Dig Dis. 2012;30 Suppl 1:32-8. doi: 10.1159/000341122. Epub 2012 Oct 11.
3
Immunogenetics in primary sclerosing cholangitis.原发性硬化性胆管炎中的免疫遗传学
Curr Opin Gastroenterol. 2017 Mar;33(2):93-98. doi: 10.1097/MOG.0000000000000336.
4
Genetics in PSC: what do the "risk genes" teach us?PSC 中的遗传学:“风险基因”告诉了我们什么?
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):154-64. doi: 10.1007/s12016-014-8417-z.
5
Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.原发性硬化性胆管炎发病机制与治疗的进展及争议
Br Med Bull. 2014 Jun;110(1):89-98. doi: 10.1093/bmb/ldu008. Epub 2014 May 2.
6
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.原发性硬化性胆管炎和溃疡性结肠炎的全基因组关联分析确定了 GPR35 和 TCF4 风险基因座。
Hepatology. 2013 Sep;58(3):1074-83. doi: 10.1002/hep.25977. Epub 2013 Jan 17.
7
Genetics in primary sclerosing cholangitis.原发性硬化性胆管炎的遗传学。
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):713-26. doi: 10.1016/j.bpg.2011.09.010.
8
Deciphering the genetic predisposition to primary sclerosing cholangitis.解析原发性硬化性胆管炎的遗传易感性。
Semin Liver Dis. 2011 May;31(2):188-207. doi: 10.1055/s-0031-1276647. Epub 2011 May 2.
9
Genetics of primary sclerosing cholangitis and pathophysiological implications.原发性硬化性胆管炎的遗传学及病理生理学意义。
Nat Rev Gastroenterol Hepatol. 2017 May;14(5):279-295. doi: 10.1038/nrgastro.2016.154. Epub 2017 Mar 15.
10
Genetics in primary sclerosing cholangitis.原发性硬化性胆管炎的遗传学。
Clin Res Hepatol Gastroenterol. 2012 Aug;36(4):325-33. doi: 10.1016/j.clinre.2012.02.003. Epub 2012 May 1.

引用本文的文献

1
Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.解析ASC依赖性炎性小体、白细胞介素-1超家族成员、血清淀粉样蛋白A以及非无菌性炎症在炎症性肠病和原发性硬化性胆管炎的疾病病理学和纤维化中的共同作用。
Int J Mol Sci. 2025 Aug 20;26(16):8042. doi: 10.3390/ijms26168042.
2
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.GPR35 通路的激活促进肿瘤微环境中的血管生成。
Gut. 2022 Mar;71(3):509-520. doi: 10.1136/gutjnl-2020-323363. Epub 2021 Mar 23.
3
Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.
CVID 中的自身免疫和炎症:免疫激活、肠道微生物群和表观遗传修饰之间的可能串扰。
J Clin Immunol. 2019 Jan;39(1):30-36. doi: 10.1007/s10875-018-0574-z. Epub 2018 Nov 21.
4
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.炎症性肠病和原发性硬化性胆管炎:表型及相关特征的综述。
Gut Liver. 2018 Jan 15;12(1):17-29. doi: 10.5009/gnl16510.
5
Genetics of primary sclerosing cholangitis and pathophysiological implications.原发性硬化性胆管炎的遗传学及病理生理学意义。
Nat Rev Gastroenterol Hepatol. 2017 May;14(5):279-295. doi: 10.1038/nrgastro.2016.154. Epub 2017 Mar 15.
6
Emerging pharmacologic therapies for primary sclerosing cholangitis.原发性硬化性胆管炎的新兴药物治疗方法。
Curr Opin Gastroenterol. 2017 May;33(3):149-157. doi: 10.1097/MOG.0000000000000352.
7
Opportunities and challenges of whole-genome and -exome sequencing.全基因组和外显子组测序的机遇与挑战
BMC Genet. 2017 Feb 14;18(1):14. doi: 10.1186/s12863-017-0479-5.
8
Colitis-associated colon cancer: Is it in your genes?结肠炎相关结肠癌:它与你的基因有关吗?
World J Gastroenterol. 2015 Nov 7;21(41):11688-99. doi: 10.3748/wjg.v21.i41.11688.
9
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.原发性硬化性胆管炎中独特的炎症性肠病表型。
World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956.
10
Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing Cholangitis.PIK3CD功能获得性突变是原发性硬化性胆管炎的一个病因。
J Clin Immunol. 2015 Jan;35(1):11-4. doi: 10.1007/s10875-014-0109-1. Epub 2014 Oct 29.